Colesevelam improved lipoprotein particle subclasses in patients with prediabetes and primary hyperlipidaemia.
(41/66)
(+info )Immobilization of heparan sulfate on electrospun meshes to support embryonic stem cell culture and differentiation.
(42/66)
(+info )The effect of a bile acid sequestrant on glucose metabolism in subjects with type 2 diabetes.
(43/66)
(+info )Colesevelam suppresses hepatic glycogenolysis by TGR5-mediated induction of GLP-1 action in DIO mice.
(44/66)
(+info )Bile acid sequestration normalizes plasma cholesterol and reduces atherosclerosis in hypercholesterolemic mice. No additional effect of physical activity.
(45/66)
(+info )Lower risk of major cardiovascular events associated with adherence to colesevelam HCI.
(46/66)
(+info )In vitro antifungal activity of naftifine hydrochloride against dermatophytes.
(47/66)
(+info )Role of colesevelam in combination lipid-lowering therapy.
(48/66)
(+info )